Skip to main content
Clinical Trials/ACTRN12623000303640
ACTRN12623000303640
Not yet recruiting
未知

Investigating the effect of supplementing with a dairy powder on improving muscle recovery after exercise in healthy individuals

Dr Jocelyn Eason0 sites40 target enrollmentMarch 17, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Muscle damage
Sponsor
Dr Jocelyn Eason
Enrollment
40
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 17, 2023
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Jocelyn Eason

Eligibility Criteria

Inclusion Criteria

  • Healthy males and females who are not involved in any comprehensive exercise training regime and can complete the physical requirements of the exercises (determined from the familiarisation day) will be selected for this study. Participants will be required to complete a health questionnaire and provide written consent for this study.

Exclusion Criteria

  • Participants will be excluded if they are unwilling or unable to provide informed written consent or comply with the study procedures. Participants will also be excluded if they (i) have known hypersensitivity or intolerance to dairy, (ii) smokers, (iii) have health conditions that impair their ability to perform the exercises or may be aggravated by the exercises in this study (e.g. injury, hernia, back or joint pain, cardiovascular and breathing problems), (iv) have a Sports Index score of 4\.5 or greater as assessed by a Baecke habitual physical activity questionnaire and (iv) are unable to perform the exercises to the standard required by the trial coordinator during the familiarisation session.
  • In addition, participants will also be excluded if they have the following health conditions: (i) blood borne diseases (e.g. hepatitis), (ii) clinically diagnosed with hypertension (high/low blood pressure) and history of fainting due to low blood pressure, (iii) recent bacterial or viral illness (2\-3 weeks) or (iv) are taking medication that impact on blood clotting: warfarin, hearing and non\-steroidal anti\-inflammatory drugs (NSAIDS).

Outcomes

Primary Outcomes

Not specified

Similar Trials